Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Instil Bio, Inc. (TIL) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Instil Bio, Inc. (TIL), most recent 12 months reported: net loss $30.28M. Latest balance sheet on file: liquid cash $69.68M, total debt $85.19M, net cash -$15.51M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): SILEXION THERAPEUTICS CORP · SCHOLAR ROCK HOLDING CORPORATION · Protara Therapeutics, Inc. · TECTONIC THERAPEUTIC, INC. · Tenaya Therapeutics, Inc. · Tevogen Inc. · Viskase Holdings, Inc. · Vor Biopharma Inc.

Stock screener

Watchlist